Murali M Yallapu

InstitutionUniversity of Texas Rio Grande Valley
AddressMcAllen
Texas
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in August 2020 and Spetember 2020 and December 2020
    All Publications
    Bar chart showing 57 publications over 13 distinct years, with a maximum of 11 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rahimi H, Salehiabar M, Barsbay M, Ghaffarlou M, Kavetskyy T, Sharafi A, Davaran S, Chauhan SC, Danafar H, Kaboli S, Nosrati H, Yallapu MM, Conde J. CRISPR Systems for COVID-19 Diagnosis. ACS Sens. 2021 04 23; 6(4):1430-1445. PMID: 33502175.
      Citations: 12     Fields:    Translation:HumansCells
    2. Kotnala S, Dhasmana A, Kashyap VK, Chauhan SC, Yallapu MM, Jaggi M. A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder. Life Sci. 2021 Mar 01; 268:118959. PMID: 33383045.
      Citations: 3     Fields:    Translation:HumansAnimals
    3. Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules. 2020 Dec 13; 25(24). PMID: 33322162.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    4. Kashyap VK, Dhasmana A, Yallapu MM, Chauhan SC, Jaggi M. Withania somnifera as a potential future drug molecule for COVID-19. Future Drug Discov. 2020 Oct 01; 2(4):FDD50. PMID: 33269342.
      Citations:    
    5. Chauhan N, Jaggi M, Chauhan SC, Yallapu MM. COVID-19: fighting the invisible enemy with microRNAs. Expert Rev Anti Infect Ther. 2021 02; 19(2):137-145. PMID: 32814446.
      Citations: 17     Fields:    Translation:HumansCells
    6. Kashyap VK, Dhasmana A, Massey A, Kotnala S, Zafar N, Jaggi M, Yallapu MM, Chauhan SC. Smoking and COVID-19: Adding Fuel to the Flame. Int J Mol Sci. 2020 Sep 09; 21(18). PMID: 32916821.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    7. Chauhan DS, Prasad R, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM. Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2. Bioconjug Chem. 2020 09 16; 31(9):2021-2045. PMID: 32680422.
      Citations: 15     Fields:    Translation:HumansPHPublic Health
    8. Laskar P, Yallapu MM, Chauhan SC. "Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies. Diseases. 2020 Aug 06; 8(3). PMID: 32781617.
      Citations: 4     
    9. Dhasmana A, Kashyap VK, Dhasmana S, Kotnala S, Haque S, Ashraf GM, Jaggi M, Yallapu MM, Chauhan SC. Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach. Curr Pharm Des. 2020; 26(41):5300-5309. PMID: 32867645.
      Citations: 1     Fields:    Translation:Humans